Updated: Athira plots an Alzheimer's comeback after scandal, PhII fail — and hints at possible accelerated approval pitch

Athira Pharma built up high hopes for its alternative approach to developing Alzheimer’s treatments, but a scandal involving doctored images, a very public …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Up­dat­ed: Athi­ra plots an Alzheimer's come­back af­ter scan­dal, PhII fail — and hints at pos­si­ble ac­cel­er­at­ed ap­proval pitch